BlackBerry Limited (LON:0R0P)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is March - February.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 25, 2025	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021
Market Capitalization	1,610	2,222	1,305	1,872	2,942	4,104
Market Cap Growth	35.64%	70.21%	-30.27%	-36.38%	-28.31%	83.49%
Enterprise Value	1,557	2,225	1,316	1,892	2,989	4,042
Last Close Price	2.89	3.88	2.02	3.15	4.95	9.19
PE Ratio	-	-	-	-	328.87	-
PS Ratio	4.07	5.23	2.17	4.31	5.50	6.40
PB Ratio	2.99	3.88	2.13	2.65	2.54	3.80
P/TBV Ratio	10.64	13.97	6.78	38.44	20.77	-
P/FCF Ratio	197.24	208.64	-	-	-	77.23
P/OCF Ratio	159.53	169.44	-	-	-	69.70
EV/Sales Ratio	3.88	5.23	2.19	4.36	5.58	6.30
EV/EBITDA Ratio	25.82	44.09	14.73	-	-	55.18
EV/EBIT Ratio	44.58	71.24	20.38	-	-	-
EV/FCF Ratio	190.70	208.93	-	-	-	76.06
Debt / Equity Ratio	0.33	0.33	0.32	0.52	0.39	0.56
Debt / EBITDA Ratio	2.94	3.19	1.94	-	-	6.34
Debt / FCF Ratio	21.43	17.84	-	-	-	11.39
Asset Turnover	0.42	0.40	0.49	0.25	0.27	0.27
Quick Ratio	1.93	1.63	1.29	0.77	2.23	2.23
Current Ratio	2.10	1.72	1.42	1.02	2.63	2.35
Return on Equity (ROE)	1.35%	-1.14%	0.69%	-17.86%	0.78%	-54.75%
Return on Assets (ROA)	2.29%	1.83%	3.32%	-1.75%	-4.97%	-1.79%
Return on Capital (ROIC)	2.97%	2.47%	4.38%	-2.15%	-5.94%	-2.13%
Return on Capital Employed (ROCE)	4.80%	4.10%	7.90%	-	-	-
Earnings Yield	-1.65%	-2.83%	-7.90%	-32.39%	0.30%	-19.32%
FCF Yield	0.51%	0.48%	-0.64%	-11.88%	-0.91%	1.29%
Buyback Yield / Dilution	-1.16%	0.17%	7.35%	-1.27%	-12.50%	8.64%

Updated Dec 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.